Login
Thu 21 Aug 2008 | 21:49 EDT
You are here:Home > News > Blogs > Good, Bad, and Ugly > Article
Home
Business & Finance
News
U.S.
Politics
International
Technology
Entertainment
Sports
Lifestyle
Oddly Enough
Environment
Health
Science
Special Coverage
Video
Pictures
You Witness
Blogs
Reader Feedback
Do More With Reuters
RSSRSS Feed
Mobile
Podcasts
Newsletters
You Witness News
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
Find a financial adviser
About Reuters

Reuters Blogs

Good, Bad, and Ugly

Reader reaction to Reuters news

« Previous Post
Next Post »
July 23rd, 2008

Doing the math

Post a comment (1)
Posted by: The Good, the Bad, & the Ugly Editor
Tags: The Good, the Bad, and the Ugly, , ,

amylin-160.gifAmylin posts wider second-quarter net loss

Revenue rose nearly 13 percent to $222 million, beating the analysts’ target of $224.3 million. Net sales of diabetes drug Byetta, which Amylin co-markets with Eli Lilly and Co, rose 17 percent to $177.5 million

If the analysts expected $224.3 million in revenue and amylin delivered $222 million, how did amylin “beat the estimates”?

Boo Dog

A good point. We corrected: GBU Editor

Comments RSS

One comment so far

August 2nd, 2008
1:10 am GMT

Just a note on the Article “World’s oldest Joke…” Thu Jul 31, 2008 11:01am EDT

I thought that there was a difference between Jokes and riddles. The world’s oldest jokes are actually riddles. (Otherwise Batman would not have had two adversaries.)

Is it just me, or has the word “Joke” been adulterated ?
(that’s a question, not a riddle.)

- Posted by George

Post Your Comment

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word